Tag: Pamrevlumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Pamrevlumab

Thomas B. Neff Sold 39636 Shares of FibroGen Inc (FGEN) Shares

Added to Collection on: 2018-11-22 08:36:23

Tags for this article:

Finance
Economy
Short
Investment
MetLife
FibroGen Inc.
Pamrevlumab

Click the tags to see associated articles and topics

View Article Details
FibroGen Appoints Maykin Ho, Ph.D., to Board of Directors

Added to Collection on: 2019-03-28 00:01:44

Tags for this article:

Biotechnology
Forward-looking statement
Pharmaceutical industry in China
Biopharmaceutical
Life Sciences
FibroGen Inc.
Acetic acids
Roxadustat
Pamrevlumab
Hypoxia-inducible factors

Click the tags to see associated articles and topics

View Article Details
Hsbc Holdings PLC Has $350000 Holdings in FibroGen Inc (FGEN)

Added to Collection on: 2019-03-29 19:41:05

Tags for this article:

Money
Finance
Economy
Stock market
Stock
Financial markets
Short
Equity securities
Share
Citigroup
Primary dealers
HSBC Holdings plc
FibroGen Inc.
Pamrevlumab

Click the tags to see associated articles and topics

View Article Details
FibroGen Provides Regulatory Update on Roxadustat

Added to Collection on: 2020-12-18 21:56:15

Tags for this article:

Branches of biology
Chemical compounds
Medical specialties
Acetic acids
Organ failure
Isoquinolines
Roxadustat
Hypoxia-inducible factors
Growth factors
Chronic kidney disease
Anemia
Pamrevlumab
FibroGen Inc.

Click the tags to see associated articles and topics

View Article Details
Surprise, surprise: AstraZeneca and FibroGen's once-hyped anemia drug roxadustat hits an FDA wall

Added to Collection on: 2021-08-11 15:22:30

Tags for this article:

Life Sciences
Biotechnology
Health care
Isoquinolines
Roxadustat
Epoetin alfa
Food and Drug Administration
Amgen
Pamrevlumab
FibroGen
United States

Click the tags to see associated articles and topics

View Article Details
FibroGen's longtime CFO hands baton to J&J veteran as high-profile roxadustat blowup cues a ...

Added to Collection on: 2021-08-16 15:22:30

Tags for this article:

Companies
Life Sciences
Health care
Pamrevlumab
AstraZeneca
Roxadustat
SVB Leerink
Oxford–AstraZeneca COVID-19 vaccine
Food and Drug Administration
FibroGen

Click the tags to see associated articles and topics

View Article Details
Idiopathic Pulmonary Fibrosis Treatment Market Size & Analysis By 2022 -2029 – Biogen ...

Added to Collection on: 2022-03-27 00:40:47

Tags for this article:

Lung disorders
Life Sciences
Pulmonary fibrosis
Idiopathic pulmonary fibrosis
Boehringer Ingelheim
Roche
Health sciences
Companies
Pamrevlumab

Click the tags to see associated articles and topics

View Article Details
FibroGen Stock Rises By 34% In The Last 21 Sessions | Via News

Added to Collection on: 2022-10-21 18:59:50

Tags for this article:

Companies
Acetic acids
Life Sciences
Monoclonal antibodies
Pamrevlumab
Roxadustat
AstraZeneca
Astellas Pharma
FibroGen Inc.

Click the tags to see associated articles and topics

View Article Details
NovaQuest Capital Management Provides $50MM Royalty Monetization Financing to FibroGen

Added to Collection on: 2022-11-08 19:09:18

Tags for this article:

Companies
Pamrevlumab
The New York Times Upfront
Astellas Pharma
Royalty payment
Periodicals
Publications
FibroGen
NovaQuest Capital Management

Click the tags to see associated articles and topics

View Article Details
FibroGen Regains All Rights to Roxadustat from AstraZeneca - GlobeNewswire

Added to Collection on: 2024-02-26 21:06:05

Tags for this article:

Isoquinolines
Roxadustat
Pamrevlumab
Astellas Pharma
AstraZeneca
Antibody-drug conjugate
Oncology
Oxford–AstraZeneca COVID-19 vaccine
Anemia
CD46
HIF prolyl-hydroxylase inhibitor
FibroGen Inc.
China

Click the tags to see associated articles and topics

View Article Details